{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:10:31Z","timestamp":1747973431283,"version":"3.41.0"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071645574","type":"print"},{"value":"9781071645581","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4558-1_2","type":"book-chapter","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:13:38Z","timestamp":1747912418000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models"],"prefix":"10.1007","author":[{"given":"Leire","family":"Arrizabalaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Bella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Augusta","family":"Di Trani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Gomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Risson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Bels\u00fae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Ardaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"8","key":"2_CR1","volume":"7","author":"F Aranda","year":"2018","unstructured":"Aranda F, Chaba K, Bloy N et al (2018) Immune effectors responsible for the elimination of hyperploid cancer cells. Onco Targets Ther 7(8):e1463947","journal-title":"Onco Targets Ther"},{"issue":"6","key":"2_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH (2021) Systemic immunity in cancer. Nat Rev Cancer 21(6):345\u2013359","journal-title":"Nat Rev Cancer"},{"key":"2_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104452","volume":"88","author":"A Mezheyeuski","year":"2023","unstructured":"Mezheyeuski A, Backman M, Mattsson J et al (2023) An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. EBioMedicine 88:104452","journal-title":"EBioMedicine"},{"issue":"1","key":"2_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"5","key":"2_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550","journal-title":"Nat Med"},{"issue":"1","key":"2_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41698-017-0031-0","volume":"1","author":"YA Lyons","year":"2017","unstructured":"Lyons YA, Wu SY, Overwijk WW et al (2017) Immune cell profiling in cancer: molecular approaches to cell-specific identification. NPJ Precis Oncol 1(1):26","journal-title":"NPJ Precis Oncol"},{"key":"2_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.612801","volume":"7","author":"DL Bonilla","year":"2020","unstructured":"Bonilla DL, Reinin G, Chua E (2020) Full spectrum flow cytometry as a powerful technology for cancer immunotherapy research. Front Mol Biosci 7:612801","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cyto.b.21984","volume":"100","author":"S Sanjabi","year":"2021","unstructured":"Sanjabi S, Lear S (2021) New cytometry tools for immune monitoring during cancer immunotherapy. Cytometry B Clin Cytom 100(1):10\u201318","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"2_CR9","first-page":"169","volume":"6","author":"C Platell","year":"2000","unstructured":"Platell C, Cooper D, Papadimitriou JM et al (2000) The omentum. World J Gastroenterol 6(2):169\u2013176","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2_CR10","first-page":"2147317","volume":"12","author":"CA Di Trani","year":"2023","unstructured":"Di Trani CA, Cirella A, Arrizabalaga L et al (2023) Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8(+) T cells eradicates peritoneal metastases in mouse models. Onco Targets Ther 12(1):2147317","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2_CR11","first-page":"2098657","volume":"11","author":"A Bella","year":"2022","unstructured":"Bella A, Arrizabalaga L, Di Trani CA et al (2022) Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. Onco Targets Ther 11(1):2098657","journal-title":"Onco Targets Ther"},{"issue":"41","key":"2_CR12","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M et al (2013) Peritoneal carcinomatosis. World J Gastroenterol 19(41):6979\u20136994","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00404-018-4784-7","volume":"298","author":"C Tempfer","year":"2018","unstructured":"Tempfer C, Giger-Pabst U, Hilal Z et al (2018) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer. Arch Gynecol Obstet 298(2):243\u2013257","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2_CR14","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e51","volume":"29","author":"T Wu","year":"2018","unstructured":"Wu T, Zhao XX, Wang GQ (2018) Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer. J Gynecol Oncol 29(4):e51","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"2_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/cgt.2016.14","volume":"23","author":"SC Katz","year":"2016","unstructured":"Katz SC, Point GR, Cunetta M et al (2016) Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Ther 23(5):142\u2013148","journal-title":"Cancer Gene Ther"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.ircmb.2022.04.016","volume":"371","author":"C Fiorentini","year":"2022","unstructured":"Fiorentini C, Sarti D, Guadagni S et al (2022) Immune response and locoregional treatments for peritoneal carcinomatosis. Int Rev Cell Mol Biol 371:97\u2013116","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"2_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ijgc-00009577-200201000-00002","volume":"12","author":"B Melichar","year":"2002","unstructured":"Melichar B, Freedman RS (2002) Immunology of the peritoneal cavity: relevance for host-tumor relation. Int J Gynecol Cancer 12(1):3\u201317","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"2_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.it.2017.03.002","volume":"38","author":"S Meza-Perez","year":"2017","unstructured":"Meza-Perez S, Randall TD (2017) Immunological functions of the omentum. Trends Immunol 38(7):526\u2013536","journal-title":"Trends Immunol"},{"issue":"4","key":"2_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/JLB.5MIR0720-271RR","volume":"109","author":"M Liu","year":"2021","unstructured":"Liu M, Silva-Sanchez A, Randall TD et al (2021) Specialized immune responses in the peritoneal cavity and omentum. J Leukoc Biol 109(4):717\u2013729","journal-title":"J Leukoc Biol"},{"issue":"8794","key":"2_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0140-6736(92)90857-Y","volume":"339","author":"RH Beelen","year":"1992","unstructured":"Beelen RH (1992) Role of omental milky spots in the local immune response. Lancet 339(8794):689","journal-title":"Lancet"},{"issue":"5","key":"2_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2009.04.005","volume":"30","author":"RE Mebius","year":"2009","unstructured":"Mebius RE (2009) Lymphoid organs for peritoneal cavity immune response: milky spots. Immunity 30(5):670\u2013672","journal-title":"Immunity"},{"key":"2_CR22","unstructured":"Bahar SG, Rokkam VR (2023) Omentum tumors. StatPearls. Treasure Island (FL) ineligible companies"},{"issue":"5","key":"2_CR23","first-page":"145","volume":"43","author":"RH Beelen","year":"1991","unstructured":"Beelen RH (1991) The greater omentum: physiology and immunological concepts. Neth J Surg 43(5):145\u2013149","journal-title":"Neth J Surg"},{"issue":"7","key":"2_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/IGC.0b013e31822127cd","volume":"21","author":"R Shroff","year":"2011","unstructured":"Shroff R, Brooks RA, Zighelboim I et al (2011) The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer. Int J Gynecol Cancer 21(7):1208\u20131212","journal-title":"Int J Gynecol Cancer"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/bs.ircmb.2022.04.017","volume":"371","author":"A Bella","year":"2022","unstructured":"Bella A, Arrizabalaga L, Di Trani CA et al (2022) Omentum: friend or foe in ovarian cancer immunotherapy? Int Rev Cell Mol Biol 371:117\u2013131","journal-title":"Int Rev Cell Mol Biol"},{"issue":"4","key":"2_CR26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ajpath.2013.06.030","volume":"183","author":"AL Sedlacek","year":"2013","unstructured":"Sedlacek AL, Gerber SA, Randall TD et al (2013) Generation of a dual-functioning antitumor immune response in the peritoneal cavity. Am J Pathol 183(4):1318\u20131328","journal-title":"Am J Pathol"},{"issue":"3","key":"2_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41416-018-0150-6","volume":"119","author":"M Knodler","year":"2018","unstructured":"Knodler M, Korfer J, Kunzmann V et al (2018) Randomised phase II trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer. Br J Cancer 119(3):296\u2013302","journal-title":"Br J Cancer"}],"container-title":["Methods in Molecular Biology","Cancer Immunosurveillance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4558-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:13:40Z","timestamp":1747912420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4558-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071645574","9781071645581"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4558-1_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"23 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}